Cyngn (CYN) to sell 2.29 million shares at $7.50/share, expects $17.2M in gross proceeds. Stock up 70%. Partnered with Nvidia ...

According to Bryant Riley, chairman and co-CEO of B. Riley, this transaction is part of a renewed commitment to focus on the ...

According to Benzinga Pro, Primoris Services's peer group average for short interest as a percentage of float is 5.66%, which ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...

According to Benzinga Pro, Casella Waste Systems's peer group average for short interest as a percentage of float is 6.72%, ...

Musculoskeletal disorders account for the largest portion of healthcare spending in the U.S., exceeding $420 billion each ...

Meta explored acquiring AI startup PlayAI. Terms undisclosed. Zuckerberg prioritizes AI for 2025. Also invested in Scale AI. Plans to compete with tech rivals.

Buying $100 In IESC: If an investor had bought $100 of IESC stock 5 years ago, it would be worth $1,254.59 today based on a price of $290.01 for IESC at the time of writing.

Brown & Brown BRO +0.53% Get Free Report has outperformed the market over the past 5 years by 7.19% on an annualized basis producing an average annual return of 21.95%. Currently, Brown & Brown has a ...

Yoo eventually partnered with chemist Syed Naqvi, who left his job to develop the formula alongside her and co-founder John Mascari. Using $75,000 in personal savings and consulting income, Yoo said ...

INmune Bio stock rose sharply on high volume ahead of topline Phase 2 trial data for XPro in early Alzheimer's, expected on June 30.

Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials and expand its bone regeneration patent portfolio.